Can a simple inhalation treatment help COVID-19 patients breathe easier?
NCT ID NCT04469491
First seen Nov 19, 2025 · Last updated Jun 18, 2026 · Updated 29 times
Summary
This study tests if inhaling a protein called interferon beta 1b can help hospitalized COVID-19 patients who need oxygen. The goal is to see if the treatment reduces the amount of oxygen they need over 15 days. The study includes 74 adults with confirmed COVID-19 who are on oxygen therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CH Compiègne-Noyon
Compiègne, 60200, France
-
CH d'Abbeville
Abbeville, 80142, France
-
CH de Saint-Quentin
Saint-Quentin, 02100, France
-
CH de Tourcoing
Tourcoing, 59208, France
-
CH de l'Arrondissement de Montreuil-sur-mer
Rang-du-Fliers, 62180, France
-
CH de valenciennes
Valenciennes, 59322, France
-
CHU Amiens
Amiens, 80480, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.